To help us deliver the best content to our users, please could you take a moment to answer a few questions? This information is anonymous and for use solely by Hedgehogs.net.
Take surveyNot now
News: Ranbaxy to pay $40 million to settle Texas litigation
67 days ago - Reuters: Money News
MUMBAI (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd said it has agreed to pay $39.75 million to settle litigation concerning its participation in Texas Medicaid, the...
News: Modi must resist U.S. pressure on drug patents - MSF
82 days ago - Reuters: Money News
NEW DELHI (Thomson Reuters Foundation) - Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce gener...
News: Free exchange: Zombie patents
182 days ago - The Economist: Finance and economics
IT IS hard to think of an industry in which competition is more important than pharmaceuticals. As health-care costs rocket, the price cuts—often of 85% or more—that gen...
News: Rite Aid's Downbeat Outlook Sends Shares Tumbling
191 days ago - Dow Jones DBR High Yield Alert
Rite Aid Corp. offered a downbeat outlook for the current period and the year, pointing to higher-than-expected drug costs stemming from a delay in meeting expected price redu...
News: Generic Drugmakers Fight Teva's Bid to Stall Competition
248 days ago - Google Alert - "Teva Pharmaceutical Industries Ltd."
Generic drugmakers asked the U.S. Supreme Court to allow them to introduce generic versions of Teva Pharmaceutical Industries Ltd.'s (NYSE:TEVA) ...
News: Indian drugmakers: Sun takes a shine to Ranbaxy
248 days ago - The Economist: Business
RANBAXY has brought Daiichi Sankyo nothing but trouble. The Japanese drugmaker paid $4.6 billion for Ranbaxy in 2008. Daiichi Sankyo wanted to expand into the burgeoning marke...
News: Meda Rejects Mylan Approach
261 days ago - WSJ.com: US Business
Swedish specialty pharmaceuticals company Meda has rejected an indicative proposal from U.S. generic drug group Mylan to combine the two businesses.
News: Abbott revenue misses on weak sales of formula, generics
333 days ago - Economy News Headlines - Yahoo News UK
Abbott Laboratories Inc reported weaker-than-expected fourth-quarter revenue, hurt by disappointing sales of its generic medicines and the lingering impact of an overseas reca...
News: Teva Pharmaceutical Industries Ltd., Actavis plc ... - The Motley Fool
347 days ago - Google Alert - "Teva Pharmaceutical Industries Ltd."
Actavis, Teva, and Mylan, which generic drug makers should be on your radar? - Brian Nichols - Health Care.
News: Lupin up on U.S. regulatory approval for generic drug
355 days ago - Reuters: Money News
Reuters Market Eye - Shares in Lupin Ltd gain 1.6 percent after U.S. Food and Drug Administration gave a tentative approval for generic version of cholesterol drug niacin, a f...
© Copyright Hedgehogs.net Limited, 2010